New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Tracking a rare and dangerous breast cancer

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or
Oncology April 01,2024
Tracking a rare and dangerous breast cancer

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or
Oncology April 01,2024
Integrated analysis finds vulnerabilities to target in a high-risk pediatric tumor

Integrated analysis finds vulnerabilities to target in a high-risk pediatric tumor

by St. Jude Children's Research HospitalElizabeth Stewart, M.D., and Hong Wang, Ph.D. of St. Jude Children's Research Hospital. Credit: St. Jude Children's Research HospitalSt. Jude C
Oncology April 01,2024
Integrated analysis finds vulnerabilities to target in a high-risk pediatric tumor

Integrated analysis finds vulnerabilities to target in a high-risk pediatric tumor

by St. Jude Children's Research HospitalElizabeth Stewart, M.D., and Hong Wang, Ph.D. of St. Jude Children's Research Hospital. Credit: St. Jude Children's Research HospitalSt. Jude C
Oncology April 01,2024
Blocking proteins could pull the plug on power for colon tumors

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at
Oncology April 01,2024
Blocking proteins could pull the plug on power for colon tumors

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at
Oncology April 01,2024
Stopping cancer from recruiting immune system double agents

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the
Oncology April 01,2024
Stopping cancer from recruiting immune system double agents

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the
Oncology April 01,2024
T-cell interactions vary between tumor microenvironments

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar
Oncology April 01,2024
T-cell interactions vary between tumor microenvironments

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar
Oncology April 01,2024
Breast cancer recurrence rate not up with autologous fat transfer

Breast cancer recurrence rate not up with autologous fat transfer

(HealthDay)—For patients with breast cancer, reconstruction with autologous fat transfer (AFT) seems not to increase the rate of locoregional recurrence versus conventional breast reconstruction, acco
Oncology April 01,2024
Breast cancer recurrence rate not up with autologous fat transfer

Breast cancer recurrence rate not up with autologous fat transfer

(HealthDay)—For patients with breast cancer, reconstruction with autologous fat transfer (AFT) seems not to increase the rate of locoregional recurrence versus conventional breast reconstruction, acco
Oncology April 01,2024
Presidential panel says high-priced cancer drugs harm patient care

Presidential panel says high-priced cancer drugs harm patient care

by Dennis Thompson, Healthday Reporter(HealthDay)—"Financial toxicity" caused by high cancer drug prices is harming people's ability to fight the dreaded disease, a new report from the P
Oncology April 01,2024
Presidential panel says high-priced cancer drugs harm patient care

Presidential panel says high-priced cancer drugs harm patient care

by Dennis Thompson, Healthday Reporter(HealthDay)—"Financial toxicity" caused by high cancer drug prices is harming people's ability to fight the dreaded disease, a new report from the P
Oncology April 01,2024
Clinical presentation of IDDMSSD syndrome likely associated with molecular location of mutation in PAK1 gene

Clinical presentation of IDDMSSD syndrome likely associated with molecular location of mutation in PAK1 gene

by Texas Children's HospitalCredit: Pixabay/CC0 Public DomainA recent study from Texas Children's Hospital and Baylor College of Medicine has expanded the clinical spectrum of a new epileptic
Breakthroughs April 01,2024
Clinical presentation of IDDMSSD syndrome likely associated with molecular location of mutation in PAK1 gene

Clinical presentation of IDDMSSD syndrome likely associated with molecular location of mutation in PAK1 gene

by Texas Children's HospitalCredit: Pixabay/CC0 Public DomainA recent study from Texas Children's Hospital and Baylor College of Medicine has expanded the clinical spectrum of a new epileptic
Breakthroughs April 01,2024
Blocking a protein to prevent injuries caused by radiation therapy

Blocking a protein to prevent injuries caused by radiation therapy

by Umea UniversityMahsa Fallah in lab. Credit: Johan GunséusIt is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma pro
Oncology April 01,2024
Blocking a protein to prevent injuries caused by radiation therapy

Blocking a protein to prevent injuries caused by radiation therapy

by Umea UniversityMahsa Fallah in lab. Credit: Johan GunséusIt is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma pro
Oncology April 01,2024
Stopping the resistance of cancer cells to treatment

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c
Oncology April 01,2024
Stopping the resistance of cancer cells to treatment

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c
Oncology April 01,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com